FIELD: medicine.
SUBSTANCE: method involves determining cytokine IL-4, IL-10, IL-12p70 and TNF-α concentration. IL-4 concentration being greater than 5.6 pg/l, IL-10 greater than 35 pg/l, IL-12p70 greater than 8.5 pg/l and TNF-α greater than 14 pg/l, marked hepatic fibrosis is considered to be the case.
EFFECT: high accuracy of diagnosis.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING SUBEPITHELIAL FIBROPLASIA FROM OCCURRING AFTER PHOTOREFRACTION KERATECTOMY | 2003 |
|
RU2272621C2 |
METHOD OF MONITORING FIBROUS PROCESS IN LIVER OF PATIENTS WITH CHRONIC HEPATITIS C | 2013 |
|
RU2557926C2 |
METHOD FOR DETERMINING PIGMENTED RETINITIS DEVELOPMENT STAGES | 2004 |
|
RU2267979C1 |
TECHNIQUE FOR DIAGNOSTICS OF HEPATIC FIBROSIS STAGES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2592371C1 |
METHOD FOR DIAGNOSTICS OF SEVERE LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C WITH GENOTYPE 1 | 2017 |
|
RU2639480C1 |
TECHNIQUE FOR DIAGNOSTICS OF HEPATIC FIBROSIS STAGES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2601113C1 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD OF LOCAL CYTOKINE EVALUATION IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS | 2007 |
|
RU2338204C1 |
Authors
Dates
2007-10-27—Published
2005-12-02—Filed